title: Author reply: To PMID 23972322.
authors.affiliation: Tennessee Retina, PC, Nashville, Tennessee.
authors.forename: Carl C
authors.initials: CC
authors.lastname: Awh
authors.affiliation: Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
authors.forename: Anne Marie
authors.initials: AM
authors.lastname: Lane
authors.affiliation: Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Canada.
authors.forename: Steven
authors.initials: S
authors.lastname: Hawken
authors.affiliation: The Ottawa Hospital Research Institute and the Division of Hematology, University of Ottawa Department of Medicine, Ottawa, Canada; The Arctic Group of Companies, Toronto, Canada.
authors.forename: Brent
authors.initials: B
authors.lastname: Zanke
authors.affiliation: Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
authors.forename: Ivana K
authors.initials: IK
authors.lastname: Kim
mesh_terms: D000975:Antioxidants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D020641:Polymorphism, Single Nucleotide; D011506:Proteins / Q000235:genetics*; D017967:Zinc Compounds / Q000627:therapeutic use*
chemical_list: D000975:Antioxidants; D011506:Proteins; D017967:Zinc Compounds